25 XP   0   0   10

Tianjin Tianyao Pharmaceuticals Co Ltd
Buy, Hold or Sell?

Let's analyse Tianjin Tianyao Pharmaceuticals Co Ltd together

PenkeI guess you are interested in Tianjin Tianyao Pharmaceuticals Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tianjin Tianyao Pharmaceuticals Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tianjin Tianyao Pharmaceuticals Co Ltd

I send you an email if I find something interesting about Tianjin Tianyao Pharmaceuticals Co Ltd.

Quick analysis of Tianjin Tianyao Pharmaceuticals Co Ltd (30 sec.)










What can you expect buying and holding a share of Tianjin Tianyao Pharmaceuticals Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥3.43
Expected worth in 1 year
¥3.44
How sure are you?
92.5%

+ What do you gain per year?

Total Gains per Share
¥0.06
Return On Investment
1.6%

For what price can you sell your share?

Current Price per Share
¥3.71
Expected price per share
¥3.1 - ¥4.05
How sure are you?
50%

1. Valuation of Tianjin Tianyao Pharmaceuticals Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥3.71

Intrinsic Value Per Share

¥6.34 - ¥20.78

Total Value Per Share

¥9.77 - ¥24.21

2. Growth of Tianjin Tianyao Pharmaceuticals Co Ltd (5 min.)




Is Tianjin Tianyao Pharmaceuticals Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$518.7m$528.3m$4.4m0.8%

How much money is Tianjin Tianyao Pharmaceuticals Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$4m$1.2m$2.8m69.8%
Net Profit Margin3.0%1.0%--

How much money comes from the company's main activities?

3. Financial Health of Tianjin Tianyao Pharmaceuticals Co Ltd (5 min.)




What can you expect buying and holding a share of Tianjin Tianyao Pharmaceuticals Co Ltd? (5 min.)

Welcome investor! Tianjin Tianyao Pharmaceuticals Co Ltd's management wants to use your money to grow the business. In return you get a share of Tianjin Tianyao Pharmaceuticals Co Ltd.

What can you expect buying and holding a share of Tianjin Tianyao Pharmaceuticals Co Ltd?

First you should know what it really means to hold a share of Tianjin Tianyao Pharmaceuticals Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Tianjin Tianyao Pharmaceuticals Co Ltd is ¥3.71. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tianjin Tianyao Pharmaceuticals Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tianjin Tianyao Pharmaceuticals Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥3.43. Based on the TTM, the Book Value Change Per Share is ¥0.00 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tianjin Tianyao Pharmaceuticals Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.00-0.1%0.000.1%0.000.0%0.000.1%0.000.1%
Usd Book Value Change Per Share-0.02-0.5%0.000.0%0.000.0%0.000.1%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.000.1%0.000.1%
Usd Total Gains Per Share-0.02-0.5%0.000.1%0.000.0%0.010.1%0.010.2%
Usd Price Per Share0.68-0.70-0.62-0.64-0.71-
Price to Earnings Ratio-38.62-14.25--27.05-11.76-48.29-
Price-to-Total Gains Ratio-35.01-72.61-303.52-125.36-150.09-
Price to Book Ratio1.43-1.43-1.29-1.37-1.87-
Price-to-Total Gains Ratio-35.01-72.61-303.52-125.36-150.09-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.512722
Number of shares1950
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.01
Gains per Quarter (1950 shares)4.0710.46
Gains per Year (1950 shares)16.2841.84
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11426192332
229422374674
3436385670116
4578547593158
572107093116200
6861286112139242
710113102130162284
811515118149186326
912917134168209368
1014419150186232410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%8.04.00.066.7%15.05.00.075.0%35.05.00.087.5%82.05.01.093.2%
Book Value Change Per Share3.01.00.075.0%8.04.00.066.7%16.04.00.080.0%35.05.00.087.5%78.010.00.088.6%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%83.00.05.094.3%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%37.03.00.092.5%83.05.00.094.3%

Fundamentals of Tianjin Tianyao Pharmaceuticals Co Ltd

About Tianjin Tianyao Pharmaceuticals Co Ltd

Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. Its primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as dosage forms, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, and tablets. It also exports its products to the United States, Southeast Asia, Europe, South America, Africa, and internationally. The company was founded in 1999 and is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. operates as a subsidiary of Tianjin Pharmaceutical Group Co., Ltd.

Fundamental data was last updated by Penke on 2024-04-17 08:12:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Tianjin Tianyao Pharmaceuticals Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tianjin Tianyao Pharmaceuticals Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Tianjin Tianyao Pharmaceuticals Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -3.7% means that ¥-0.04 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The MRQ is -3.7%. The company is making a loss. -1
  • The TTM is 3.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ-3.7%TTM3.0%-6.7%
TTM3.0%YOY1.0%+2.0%
TTM3.0%5Y2.3%+0.7%
5Y2.3%10Y4.1%-1.8%
1.1.2. Return on Assets

Shows how efficient Tianjin Tianyao Pharmaceuticals Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tianjin Tianyao Pharmaceuticals Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.6% Return on Assets means that Tianjin Tianyao Pharmaceuticals Co Ltd generated ¥-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The MRQ is -0.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-0.6%TTM0.4%-1.0%
TTM0.4%YOY0.1%+0.3%
TTM0.4%5Y0.3%+0.1%
5Y0.3%10Y0.5%-0.2%
1.1.3. Return on Equity

Shows how efficient Tianjin Tianyao Pharmaceuticals Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tianjin Tianyao Pharmaceuticals Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.2% Return on Equity means Tianjin Tianyao Pharmaceuticals Co Ltd generated ¥-0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The MRQ is -1.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is 0.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM0.9%-2.1%
TTM0.9%YOY0.3%+0.6%
TTM0.9%5Y0.6%+0.3%
5Y0.6%10Y0.8%-0.2%

1.2. Operating Efficiency of Tianjin Tianyao Pharmaceuticals Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tianjin Tianyao Pharmaceuticals Co Ltd is operating .

  • Measures how much profit Tianjin Tianyao Pharmaceuticals Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tianjin Tianyao Pharmaceuticals Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.7%-0.7%
TTM0.7%YOY5.0%-4.3%
TTM0.7%5Y5.2%-4.5%
5Y5.2%10Y3.5%+1.7%
1.2.2. Operating Ratio

Measures how efficient Tianjin Tianyao Pharmaceuticals Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.63 means that the operating costs are ¥1.63 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The MRQ is 1.634. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.474. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.634TTM1.474+0.160
TTM1.474YOY1.443+0.031
TTM1.4745Y1.445+0.029
5Y1.44510Y1.141+0.304

1.3. Liquidity of Tianjin Tianyao Pharmaceuticals Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tianjin Tianyao Pharmaceuticals Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.09 means the company has ¥1.09 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The MRQ is 1.086. The company is just able to pay all its short-term debts.
  • The TTM is 1.115. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.086TTM1.115-0.029
TTM1.115YOY0.992+0.123
TTM1.1155Y1.130-0.015
5Y1.13010Y0.727+0.403
1.3.2. Quick Ratio

Measures if Tianjin Tianyao Pharmaceuticals Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tianjin Tianyao Pharmaceuticals Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.22 means the company can pay off ¥0.22 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The MRQ is 0.222. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.247. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.222TTM0.247-0.026
TTM0.247YOY0.268-0.020
TTM0.2475Y0.274-0.027
5Y0.27410Y0.611-0.337

1.4. Solvency of Tianjin Tianyao Pharmaceuticals Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tianjin Tianyao Pharmaceuticals Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tianjin Tianyao Pharmaceuticals Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.39 means that Tianjin Tianyao Pharmaceuticals Co Ltd assets are financed with 38.9% credit (debt) and the remaining percentage (100% - 38.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The MRQ is 0.389. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.396. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.389TTM0.396-0.007
TTM0.396YOY0.409-0.013
TTM0.3965Y0.381+0.015
5Y0.38110Y0.302+0.079
1.4.2. Debt to Equity Ratio

Measures if Tianjin Tianyao Pharmaceuticals Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tianjin Tianyao Pharmaceuticals Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 80.9% means that company has ¥0.81 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The MRQ is 0.809. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.830. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.809TTM0.830-0.021
TTM0.830YOY0.880-0.050
TTM0.8305Y0.779+0.051
5Y0.77910Y0.547+0.232

2. Market Valuation of Tianjin Tianyao Pharmaceuticals Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Tianjin Tianyao Pharmaceuticals Co Ltd generates.

  • Above 15 is considered overpriced but always compare Tianjin Tianyao Pharmaceuticals Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -38.62 means the investor is paying ¥-38.62 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The EOD is -29.243. Based on the earnings, the company is expensive. -2
  • The MRQ is -38.622. Based on the earnings, the company is expensive. -2
  • The TTM is 14.248. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-29.243MRQ-38.622+9.380
MRQ-38.622TTM14.248-52.870
TTM14.248YOY-27.052+41.299
TTM14.2485Y11.762+2.485
5Y11.76210Y48.287-36.525
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The EOD is 3.697. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 4.883. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 9.907. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.697MRQ4.883-1.186
MRQ4.883TTM9.907-5.024
TTM9.907YOY27.669-17.762
TTM9.9075Y19.043-9.136
5Y19.04310Y-19.000+38.043
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tianjin Tianyao Pharmaceuticals Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Tianjin Tianyao Pharmaceuticals Co Ltd:

  • The EOD is 1.081. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.428. Based on the equity, the company is underpriced. +1
  • The TTM is 1.432. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.081MRQ1.428-0.347
MRQ1.428TTM1.432-0.004
TTM1.432YOY1.290+0.143
TTM1.4325Y1.367+0.065
5Y1.36710Y1.873-0.506
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tianjin Tianyao Pharmaceuticals Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1430.002-8161%-0.011-92%0.022-766%0.033-540%
Book Value Per Share--3.4313.519-2%3.478-1%3.401+1%2.928+17%
Current Ratio--1.0861.115-3%0.992+9%1.130-4%0.727+49%
Debt To Asset Ratio--0.3890.396-2%0.409-5%0.381+2%0.302+29%
Debt To Equity Ratio--0.8090.830-2%0.880-8%0.779+4%0.547+48%
Dividend Per Share--0.0030.013-74%0.015-77%0.017-80%0.020-83%
Eps---0.0320.027-219%0.008-495%0.017-283%0.020-256%
Free Cash Flow Per Share--0.2510.148+69%0.103+144%0.043+488%0.037+570%
Free Cash Flow To Equity Per Share--0.2510.074+239%0.074+241%0.029+764%0.039+542%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--20.783--------
Intrinsic Value_10Y_min--6.343--------
Intrinsic Value_1Y_max--0.575--------
Intrinsic Value_1Y_min--0.234--------
Intrinsic Value_3Y_max--2.876--------
Intrinsic Value_3Y_min--1.055--------
Intrinsic Value_5Y_max--6.562--------
Intrinsic Value_5Y_min--2.255--------
Market Cap4058480240.640-32%5360270132.0005524973963.900-3%4930022749.800+9%5102934704.388+5%5641546074.498-5%
Net Profit Margin---0.0370.030-222%0.010-462%0.023-261%0.041-190%
Operating Margin---0.007-100%0.050-100%0.052-100%0.035-100%
Operating Ratio--1.6341.474+11%1.443+13%1.445+13%1.141+43%
Pb Ratio1.081-32%1.4281.4320%1.290+11%1.367+4%1.873-24%
Pe Ratio-29.243+24%-38.62214.248-371%-27.052-30%11.762-428%48.287-180%
Price Per Share3.710-32%4.9005.043-3%4.485+9%4.649+5%5.149-5%
Price To Free Cash Flow Ratio3.697-32%4.8839.907-51%27.669-82%19.043-74%-19.000+489%
Price To Total Gains Ratio-26.508+24%-35.01172.614-148%303.518-112%125.357-128%150.088-123%
Quick Ratio--0.2220.247-10%0.268-17%0.274-19%0.611-64%
Return On Assets---0.0060.004-228%0.001-499%0.003-272%0.005-209%
Return On Equity---0.0120.009-225%0.003-503%0.006-283%0.008-243%
Total Gains Per Share---0.1400.015-1027%0.004-3689%0.039-461%0.053-366%
Usd Book Value--518706604.330532790921.624-3%528341585.422-2%515985424.924+1%443564792.899+17%
Usd Book Value Change Per Share---0.0200.000-8161%-0.002-92%0.003-766%0.005-540%
Usd Book Value Per Share--0.4740.486-2%0.481-1%0.470+1%0.405+17%
Usd Dividend Per Share--0.0000.002-74%0.002-77%0.002-80%0.003-83%
Usd Eps---0.0040.004-219%0.001-495%0.002-283%0.003-256%
Usd Free Cash Flow--37928044.86122452668.367+69%15593293.521+143%6467288.175+486%5382581.284+605%
Usd Free Cash Flow Per Share--0.0350.020+69%0.014+144%0.006+488%0.005+570%
Usd Free Cash Flow To Equity Per Share--0.0350.010+239%0.010+241%0.004+764%0.005+542%
Usd Market Cap560881969.256-32%740789332.242763551401.811-3%681329144.022+9%705225576.146+5%779661667.496-5%
Usd Price Per Share0.513-32%0.6770.697-3%0.620+9%0.642+5%0.712-5%
Usd Profit---4795082.0814044164.583-219%1223283.397-492%2628449.440-282%3084471.213-255%
Usd Revenue--130605629.769130696659.7610%127452529.188+2%119218020.698+10%88632895.145+47%
Usd Total Gains Per Share---0.0190.002-1027%0.001-3689%0.005-461%0.007-366%
 EOD+4 -4MRQTTM+11 -24YOY+14 -215Y+14 -2110Y+13 -22

3.2. Fundamental Score

Let's check the fundamental score of Tianjin Tianyao Pharmaceuticals Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-29.243
Price to Book Ratio (EOD)Between0-11.081
Net Profit Margin (MRQ)Greater than0-0.037
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.222
Current Ratio (MRQ)Greater than11.086
Debt to Asset Ratio (MRQ)Less than10.389
Debt to Equity Ratio (MRQ)Less than10.809
Return on Equity (MRQ)Greater than0.15-0.012
Return on Assets (MRQ)Greater than0.05-0.006
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Tianjin Tianyao Pharmaceuticals Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.760
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Operating Income  63,98575,250139,235-60,83178,404-28,70549,699-72,747-23,048



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets6,142,482
Total Liabilities2,389,178
Total Stockholder Equity2,953,554
 As reported
Total Liabilities 2,389,178
Total Stockholder Equity+ 2,953,554
Total Assets = 6,142,482

Assets

Total Assets6,142,482
Total Current Assets2,108,068
Long-term Assets4,034,414
Total Current Assets
Cash And Cash Equivalents 718,856
Net Receivables 429,951
Inventory 725,581
Other Current Assets 6,941
Total Current Assets  (as reported)2,108,068
Total Current Assets  (calculated)1,881,329
+/- 226,739
Long-term Assets
Property Plant Equipment 3,069,179
Intangible Assets 472,072
Long-term Assets Other 287,152
Long-term Assets  (as reported)4,034,414
Long-term Assets  (calculated)3,828,403
+/- 206,011

Liabilities & Shareholders' Equity

Total Current Liabilities1,940,299
Long-term Liabilities448,879
Total Stockholder Equity2,953,554
Total Current Liabilities
Short Long Term Debt 270,253
Accounts payable 719,552
Other Current Liabilities 16,872
Total Current Liabilities  (as reported)1,940,299
Total Current Liabilities  (calculated)1,006,676
+/- 933,623
Long-term Liabilities
Long term Debt 277,000
Long-term Liabilities Other 713
Long-term Liabilities  (as reported)448,879
Long-term Liabilities  (calculated)277,713
+/- 171,166
Total Stockholder Equity
Retained Earnings 1,257,721
Total Stockholder Equity (as reported)2,953,554
Total Stockholder Equity (calculated)1,257,721
+/- 1,695,833
Other
Capital Stock1,093,933
Common Stock Shares Outstanding 1,093,933
Net Invested Capital 3,500,807
Net Working Capital 167,769
Property Plant and Equipment Gross 3,069,179



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-31
> Total Assets 
502,777
1,006,960
1,134,021
1,317,584
1,306,769
1,366,014
1,419,005
1,481,593
1,507,371
1,479,664
1,604,898
1,613,699
1,515,690
1,476,906
1,528,578
1,584,187
1,757,298
1,830,366
1,978,051
2,158,518
2,185,444
2,101,487
2,425,348
2,410,131
2,367,940
2,303,916
2,315,370
2,255,406
2,306,675
2,417,592
2,571,838
2,506,255
2,530,110
2,506,755
2,623,501
2,815,521
3,189,114
2,885,082
2,919,747
2,959,354
2,947,499
2,852,380
2,416,722
2,373,335
2,569,162
2,389,158
2,491,966
3,057,892
3,026,972
3,048,852
3,111,598
3,072,240
3,061,870
2,964,027
2,896,799
2,941,410
2,999,915
3,041,283
3,033,179
3,033,760
2,989,186
3,014,984
3,001,729
3,078,285
4,178,757
4,275,237
4,283,034
4,445,466
4,275,647
4,525,256
4,800,471
4,817,741
5,327,126
5,329,494
5,281,177
5,348,196
5,991,927
6,043,789
6,176,060
6,348,303
6,346,190
6,345,509
6,345,015
6,390,317
6,379,988
6,473,553
6,650,700
6,621,276
6,516,514
6,266,054
6,142,482
6,142,4826,266,0546,516,5146,621,2766,650,7006,473,5536,379,9886,390,3176,345,0156,345,5096,346,1906,348,3036,176,0606,043,7895,991,9275,348,1965,281,1775,329,4945,327,1264,817,7414,800,4714,525,2564,275,6474,445,4664,283,0344,275,2374,178,7573,078,2853,001,7293,014,9842,989,1863,033,7603,033,1793,041,2832,999,9152,941,4102,896,7992,964,0273,061,8703,072,2403,111,5983,048,8523,026,9723,057,8922,491,9662,389,1582,569,1622,373,3352,416,7222,852,3802,947,4992,959,3542,919,7472,885,0823,189,1142,815,5212,623,5012,506,7552,530,1102,506,2552,571,8382,417,5922,306,6752,255,4062,315,3702,303,9162,367,9402,410,1312,425,3482,101,4872,185,4442,158,5181,978,0511,830,3661,757,2981,584,1871,528,5781,476,9061,515,6901,613,6991,604,8981,479,6641,507,3711,481,5931,419,0051,366,0141,306,7691,317,5841,134,0211,006,960502,777
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,839,277
2,046,410
2,215,975
2,177,884
2,131,736
2,140,818
1,852,400
1,882,828
2,098,853
2,013,075
1,886,479
2,024,196
1,937,739
1,945,741
1,882,568
1,922,071
1,945,528
2,093,423
2,360,490
2,380,509
2,301,135
2,068,574
2,108,068
2,108,0682,068,5742,301,1352,380,5092,360,4902,093,4231,945,5281,922,0711,882,5681,945,7411,937,7392,024,1961,886,4792,013,0752,098,8531,882,8281,852,4002,140,8182,131,7362,177,8842,215,9752,046,4101,839,27700000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
275,335
490,506
337,669
343,563
267,530
236,895
245,887
181,836
238,745
255,250
244,370
249,259
201,083
230,337
232,216
273,629
317,295
550,385
647,742
670,742
551,683
455,312
718,856
718,856455,312551,683670,742647,742550,385317,295273,629232,216230,337201,083249,259244,370255,250238,745181,836245,887236,895267,530343,563337,669490,506275,33500000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
129
0
0
0
000129000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
82,596
44,330
42,074
98,687
117,638
126,375
162,296
172,866
191,832
206,719
232,858
271,694
186,375
225,530
188,381
224,769
244,672
343,013
249,431
327,488
310,048
302,418
256,510
283,609
294,335
227,816
199,595
222,165
178,988
154,228
157,019
186,647
171,849
178,701
144,684
193,523
159,482
143,070
106,516
164,538
193,813
134,581
142,657
200,796
211,483
197,515
203,161
218,508
208,377
223,094
245,907
302,676
322,789
329,656
289,149
267,562
316,611
296,332
219,251
239,055
288,117
271,688
252,095
301,929
438,165
400,467
397,294
498,082
491,853
403,569
340,671
337,223
384,461
329,660
342,825
545,903
604,488
467,607
503,565
551,644
620,384
660,238
627,129
669,454
664,244
538,983
342,135
369,617
709,255
441,396
429,951
429,951441,396709,255369,617342,135538,983664,244669,454627,129660,238620,384551,644503,565467,607604,488545,903342,825329,660384,461337,223340,671403,569491,853498,082397,294400,467438,165301,929252,095271,688288,117239,055219,251296,332316,611267,562289,149329,656322,789302,676245,907223,094208,377218,508203,161197,515211,483200,796142,657134,581193,813164,538106,516143,070159,482193,523144,684178,701171,849186,647157,019154,228178,988222,165199,595227,816294,335283,609256,510302,418310,048327,488249,431343,013244,672224,769188,381225,530186,375271,694232,858206,719191,832172,866162,296126,375117,63898,68742,07444,33082,596
       Other Current Assets 
10,861
3,267
12,826
13,822
15,266
13,892
10,010
16,000
12,842
14,878
9,584
170,563
22,351
2,281
3,512
5,868
3,198
7,317
19,785
34,853
17,714
29,697
3,447
58,690
58,109
71,551
54,694
78,373
105,134
124,710
107,748
103,173
100,928
106,522
109,150
93,583
157,865
147,590
168,683
115,441
130,676
97,380
107,477
96,643
85,467
74,009
62,256
67,347
151,670
33,918
44,805
29,003
29,255
30,570
10,207
25,745
26,429
26,567
17,076
221,518
9,823
157,463
31,250
204,144
11,549
214,850
8,232
60,229
21,652
20,349
14,873
9,717
6,997
41,633
20,006
42,295
55,038
63,030
33,812
64,055
42,328
45,520
47,584
53,494
22,796
23,599
17,896
31,803
32,786
714
6,941
6,94171432,78631,80317,89623,59922,79653,49447,58445,52042,32864,05533,81263,03055,03842,29520,00641,6336,9979,71714,87320,34921,65260,2298,232214,85011,549204,14431,250157,4639,823221,51817,07626,56726,42925,74510,20730,57029,25529,00344,80533,918151,67067,34762,25674,00985,46796,643107,47797,380130,676115,441168,683147,590157,86593,583109,150106,522100,928103,173107,748124,710105,13478,37354,69471,55158,10958,6903,44729,69717,71434,85319,7857,3173,1985,8683,5122,28122,351170,5639,58414,87812,84216,00010,01013,89215,26613,82212,8263,26710,861
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,639,857
3,195,390
3,188,676
3,428,778
3,465,369
3,893,075
4,030,714
4,289,581
4,324,107
4,408,450
4,399,768
4,462,447
4,468,247
4,434,460
4,380,130
4,290,210
4,240,767
4,215,379
4,197,481
4,034,414
4,034,4144,197,4814,215,3794,240,7674,290,2104,380,1304,434,4604,468,2474,462,4474,399,7684,408,4504,324,1074,289,5814,030,7143,893,0753,465,3693,428,7783,188,6763,195,3902,639,85700000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
209,257
210,897
246,075
265,525
318,880
348,421
389,157
486,479
502,244
516,275
563,456
568,323
594,684
628,386
682,582
720,268
739,956
746,073
823,972
882,197
880,114
863,719
869,489
835,784
981,704
933,907
1,085,028
992,728
1,134,027
1,113,571
1,359,742
1,298,771
1,435,923
1,355,357
1,381,770
1,309,342
1,424,965
1,324,932
1,059,115
1,080,556
1,127,484
1,111,602
1,117,945
1,134,478
1,162,763
1,188,122
1,186,867
1,188,078
1,315,993
1,427,143
1,416,124
1,408,833
1,394,285
1,379,763
1,389,375
1,374,854
1,363,148
1,362,271
1,354,577
1,346,914
1,337,998
1,326,564
1,325,039
1,317,053
1,974,858
1,980,047
2,061,030
2,064,664
2,043,547
2,064,792
2,127,131
2,150,004
2,615,927
2,628,597
2,704,775
2,731,105
3,003,398
3,050,508
3,226,433
3,270,574
3,291,493
3,309,674
3,348,039
3,340,170
3,317,090
3,220,930
3,174,271
3,142,022
3,096,908
3,080,994
3,069,179
3,069,1793,080,9943,096,9083,142,0223,174,2713,220,9303,317,0903,340,1703,348,0393,309,6743,291,4933,270,5743,226,4333,050,5083,003,3982,731,1052,704,7752,628,5972,615,9272,150,0042,127,1312,064,7922,043,5472,064,6642,061,0301,980,0471,974,8581,317,0531,325,0391,326,5641,337,9981,346,9141,354,5771,362,2711,363,1481,374,8541,389,3751,379,7631,394,2851,408,8331,416,1241,427,1431,315,9931,188,0781,186,8671,188,1221,162,7631,134,4781,117,9451,111,6021,127,4841,080,5561,059,1151,324,9321,424,9651,309,3421,381,7701,355,3571,435,9231,298,7711,359,7421,113,5711,134,027992,7281,085,028933,907981,704835,784869,489863,719880,114882,197823,972746,073739,956720,268682,582628,386594,684568,323563,456516,275502,244486,479389,157348,421318,880265,525246,075210,897209,257
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
116,534
117,168
117,341
116,770
112,432
109,762
250,049
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000250,049109,762112,432116,770117,341117,168116,53400000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
21,486
20,220
21,832
21,332
20,954
20,298
24,530
23,747
22,964
24,569
23,767
22,964
22,162
21,360
22,642
21,919
16,739
20,883
18,549
21,995
16,824
20,625
15,626
133,090
14,815
118,318
11,098
119,746
12,276
116,049
12,164
124,791
8,521
120,787
9,923
122,644
11,787
123,991
14,270
29,976
10,172
21,916
7,584
20,181
4,485
15,998
7,221
18,499
2,930
15,213
12,533
28,248
33,639
31,971
30,525
29,219
37,685
41,262
36,830
36,274
35,439
34,883
34,326
33,815
51,725
51,029
64,037
63,106
62,035
60,965
61,814
135,553
117,038
147,496
167,148
173,074
212,618
232,968
252,047
269,478
281,191
316,281
341,952
357,355
390,630
393,256
427,897
427,312
445,115
444,562
472,072
472,072444,562445,115427,312427,897393,256390,630357,355341,952316,281281,191269,478252,047232,968212,618173,074167,148147,496117,038135,55361,81460,96562,03563,10664,03751,02951,72533,81534,32634,88335,43936,27436,83041,26237,68529,21930,52531,97133,63928,24812,53315,2132,93018,4997,22115,9984,48520,1817,58421,91610,17229,97614,270123,99111,787122,6449,923120,7878,521124,79112,164116,04912,276119,74611,098118,31814,815133,09015,62620,62516,82421,99518,54920,88316,73921,91922,64221,36022,16222,96423,76724,56922,96423,74724,53020,29820,95421,33221,83220,22021,486
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
202,961
285,004
266,964
272,402
281,264
343,937
3,458,424
370,967
337,747
389,485
380,776
378,312
372,334
349,231
361,488
338,693
325,580
319,049
316,297
287,152
287,152316,297319,049325,580338,693361,488349,231372,334378,312380,776389,485337,747370,9673,458,424343,937281,264272,402266,964285,004202,96100000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
291,031
309,102
419,394
561,426
522,675
560,146
634,497
620,137
626,322
574,544
669,248
652,041
571,933
512,778
541,104
601,285
749,674
801,516
933,425
1,099,673
1,121,612
1,027,572
1,347,885
1,328,506
916,200
844,803
854,651
797,061
831,825
922,652
1,067,930
991,021
1,014,332
969,754
1,067,489
1,246,623
1,616,712
1,287,551
1,288,180
1,311,410
1,297,065
1,197,670
729,861
669,441
861,392
652,280
724,127
750,408
713,592
721,778
785,644
726,125
717,774
596,279
501,341
531,496
584,192
600,289
584,420
569,100
524,176
539,083
511,214
579,977
1,123,789
1,187,584
1,153,774
1,277,038
1,087,337
1,288,074
1,518,307
1,483,768
1,921,566
1,892,982
1,695,233
1,712,429
2,263,147
2,287,177
2,403,470
2,520,023
2,498,460
2,534,795
2,528,155
2,550,879
2,526,031
2,628,699
2,896,862
2,778,281
2,610,424
2,347,578
2,389,178
2,389,1782,347,5782,610,4242,778,2812,896,8622,628,6992,526,0312,550,8792,528,1552,534,7952,498,4602,520,0232,403,4702,287,1772,263,1471,712,4291,695,2331,892,9821,921,5661,483,7681,518,3071,288,0741,087,3371,277,0381,153,7741,187,5841,123,789579,977511,214539,083524,176569,100584,420600,289584,192531,496501,341596,279717,774726,125785,644721,778713,592750,408724,127652,280861,392669,441729,8611,197,6701,297,0651,311,4101,288,1801,287,5511,616,7121,246,6231,067,489969,7541,014,332991,0211,067,930922,652831,825797,061854,651844,803916,2001,328,5061,347,8851,027,5721,121,6121,099,673933,425801,516749,674601,285541,104512,778571,933652,041669,248574,544626,322620,137634,497560,146522,675561,426419,394309,102291,031
   > Total Current Liabilities 
250,980
103,551
413,643
553,558
417,102
454,493
328,066
313,206
619,391
567,613
664,097
646,890
268,681
209,527
238,253
298,433
747,173
800,415
932,377
1,098,725
1,120,664
1,026,323
956,102
937,808
915,733
844,437
854,606
796,960
831,601
922,441
1,067,930
991,021
764,332
719,755
816,799
945,233
915,322
586,161
616,790
710,020
1,295,675
1,197,670
712,873
642,490
434,441
225,330
193,268
225,879
589,063
597,249
763,537
704,017
505,667
199,171
104,999
135,153
387,849
588,947
574,387
559,054
314,167
144,074
118,996
187,704
1,098,036
1,161,827
1,129,363
1,251,977
860,776
876,513
1,107,984
1,073,445
1,675,299
1,825,635
1,606,282
1,625,335
1,892,383
1,720,947
1,805,448
1,808,115
1,814,908
2,055,460
2,023,548
2,036,210
2,058,385
2,004,229
2,280,100
2,170,002
1,956,921
1,876,103
1,940,299
1,940,2991,876,1031,956,9212,170,0022,280,1002,004,2292,058,3852,036,2102,023,5482,055,4601,814,9081,808,1151,805,4481,720,9471,892,3831,625,3351,606,2821,825,6351,675,2991,073,4451,107,984876,513860,7761,251,9771,129,3631,161,8271,098,036187,704118,996144,074314,167559,054574,387588,947387,849135,153104,999199,171505,667704,017763,537597,249589,063225,879193,268225,330434,441642,490712,8731,197,6701,295,675710,020616,790586,161915,322945,233816,799719,755764,332991,0211,067,930922,441831,601796,960854,606844,437915,733937,808956,1021,026,3231,120,6641,098,725932,377800,415747,173298,433238,253209,527268,681646,890664,097567,613619,391313,206328,066454,493417,102553,558413,643103,551250,980
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
305,135
462,742
464,519
494,667
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000494,667464,519462,742305,13500000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
305,135
462,742
464,519
494,667
458,596
609,131
572,373
830,558
725,215
577,491
578,209
588,626
629,531
594,048
648,309
648,338
539,366
448,728
270,105
270,253
270,253270,105448,728539,366648,338648,309594,048629,531588,626578,209577,491725,215830,558572,373609,131458,596494,667464,519462,742305,13500000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
40,138
35,705
33,951
37,839
36,591
39,445
49,944
47,458
50,528
57,315
59,161
71,594
63,854
54,002
62,743
72,569
98,109
110,540
171,457
252,172
197,265
142,356
131,420
123,783
96,693
79,790
107,232
128,648
107,326
124,037
228,552
234,282
322,709
286,553
366,097
316,174
664,870
314,635
305,759
268,397
267,811
220,468
179,182
146,593
347,333
150,118
120,374
99,394
96,229
99,633
122,501
100,094
128,959
117,750
85,185
85,012
131,501
160,899
154,951
157,975
113,005
127,877
100,137
163,412
166,198
208,088
202,235
188,015
234,981
204,862
600,781
657,883
641,906
659,834
436,173
462,191
712,419
760,038
592,172
678,489
600,964
650,207
565,938
532,102
599,931
610,010
792,901
801,947
756,111
692,961
719,552
719,552692,961756,111801,947792,901610,010599,931532,102565,938650,207600,964678,489592,172760,038712,419462,191436,173659,834641,906657,883600,781204,862234,981188,015202,235208,088166,198163,412100,137127,877113,005157,975154,951160,899131,50185,01285,185117,750128,959100,094122,50199,63396,22999,394120,374150,118347,333146,593179,182220,468267,811268,397305,759314,635664,870316,174366,097286,553322,709234,282228,552124,037107,326128,648107,23279,79096,693123,783131,420142,356197,265252,172171,457110,54098,10972,56962,74354,00263,85471,59459,16157,31550,52847,45849,94439,44536,59137,83933,95135,70540,138
       Other Current Liabilities 
5,842
67,846
37,392
47,719
10,311
15,048
57,557
52,048
68,737
21,776
14,184
16,684
19,009
9,722
13,722
45,220
0
0
0
0
0
0
8,337
35,508
26,634
29,989
9,728
26,243
14,977
9,556
15,105
10,366
26,670
31,895
41,719
56,536
38,833
34,956
66,892
48,406
48,605
47,886
57,827
26,412
19,663
24,234
26,546
39,493
30,451
26,518
121,847
39,997
27,772
34,573
16,661
20,353
28,833
43,049
20,790
16,079
16,162
16,197
18,859
24,292
525,982
568,739
532,700
678,962
44,999
231,456
82,766
82,388
215,000
385,000
240,908
277,578
310,367
336,448
342,704
379,383
310,810
344,899
352,893
389,623
306,921
397,387
17,638
12,768
375,278
11,094
16,872
16,87211,094375,27812,76817,638397,387306,921389,623352,893344,899310,810379,383342,704336,448310,367277,578240,908385,000215,00082,38882,766231,45644,999678,962532,700568,739525,98224,29218,85916,19716,16216,07920,79043,04928,83320,35316,66134,57327,77239,997121,84726,51830,45139,49326,54624,23419,66326,41257,82747,88648,60548,40666,89234,95638,83356,53641,71931,89526,67010,36615,1059,55614,97726,2439,72829,98926,63435,5088,33700000045,22013,7229,72219,00916,68414,18421,77668,73752,04857,55715,04810,31147,71937,39267,8465,842
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
410,323
246,266
67,347
88,951
87,094
370,764
566,230
598,021
711,908
683,552
479,335
504,606
514,669
467,646
624,470
616,762
608,279
653,503
471,475
448,879
448,879471,475653,503608,279616,762624,470467,646514,669504,606479,335683,552711,908598,021566,230370,76487,09488,95167,347246,266410,32300000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-305,135
-462,742
-464,519
-494,667
0
0
0
0
181
121
65
274
278
141
75
115
74
40
14
0
014407411575141278274651211810000-494,667-464,519-462,742-305,13500000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
385,000
185,000
0
0
0
200,000
50,000
0
50,000
0
0
0
0
0
1,260
1,008
1,008
1,008
951
713
7139511,0081,0081,0081,2600000050,000050,000200,000000185,000385,00000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86,812
86,521
75,123
77,664
79,168
81,954
100,965
103,827
110,852
119,558
133,978
137,550
151,597
137,503
150,972
149,540
158,943
167,743
175,110
178,095
170,191
0
0
00170,191178,095175,110167,743158,943149,540150,972137,503151,597137,550133,978119,558110,852103,827100,96581,95479,16877,66475,12386,52186,81200000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
211,746
697,857
709,231
732,597
759,675
780,643
759,364
817,358
836,366
859,371
888,182
914,251
896,044
916,108
940,079
935,218
960,310
980,987
996,419
1,010,523
1,015,451
1,025,212
1,028,452
1,032,043
1,420,530
1,426,963
1,429,654
1,426,997
1,443,245
1,458,710
1,468,569
1,479,717
1,479,793
1,499,091
1,517,643
1,529,957
1,532,887
1,557,510
1,591,237
1,607,397
1,609,547
1,634,474
1,666,420
1,683,434
1,687,408
1,716,432
1,747,326
2,286,965
2,292,829
2,306,504
2,305,368
2,325,452
2,323,414
2,347,048
2,374,733
2,389,170
2,394,960
2,420,212
2,427,950
2,443,832
2,444,163
2,455,035
2,469,542
2,477,315
2,657,767
2,682,841
2,718,792
2,746,335
2,764,278
2,802,213
2,837,954
2,878,780
2,756,711
2,781,522
2,919,952
2,954,980
2,957,110
2,978,974
2,991,519
3,021,289
3,031,573
2,990,332
2,993,025
3,017,951
3,024,578
3,044,909
2,972,508
3,042,516
3,092,845
3,122,129
2,953,554
2,953,5543,122,1293,092,8453,042,5162,972,5083,044,9093,024,5783,017,9512,993,0252,990,3323,031,5733,021,2892,991,5192,978,9742,957,1102,954,9802,919,9522,781,5222,756,7112,878,7802,837,9542,802,2132,764,2782,746,3352,718,7922,682,8412,657,7672,477,3152,469,5422,455,0352,444,1632,443,8322,427,9502,420,2122,394,9602,389,1702,374,7332,347,0482,323,4142,325,4522,305,3682,306,5042,292,8292,286,9651,747,3261,716,4321,687,4081,683,4341,666,4201,634,4741,609,5471,607,3971,591,2371,557,5101,532,8871,529,9571,517,6431,499,0911,479,7931,479,7171,468,5691,458,7101,443,2451,426,9971,429,6541,426,9631,420,5301,032,0431,028,4521,025,2121,015,4511,010,523996,419980,987960,310935,218940,079916,108896,044914,251888,182859,371836,366817,358759,364780,643759,675732,597709,231697,857211,746
   Common Stock
104,009
149,009
149,009
149,009
193,712
193,712
193,712
193,712
251,825
251,825
251,825
251,825
251,825
251,825
251,825
251,825
251,825
251,825
251,825
251,825
453,285
453,285
453,285
453,285
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
542,890
960,855
960,855
960,855
960,855
960,855
960,855
960,855
960,855
960,855
960,855
960,855
960,855
960,855
960,855
960,855
960,855
960,855
1,091,887
1,091,887
1,091,887
1,091,887
1,091,887
1,091,887
1,091,887
1,091,887
1,091,887
1,091,887
1,091,887
1,091,887
1,100,907
1,100,907
1,100,787
1,100,787
1,100,787
1,100,347
1,100,047
1,100,047
1,096,363
1,096,363
1,096,363
0
1,093,933
0
0
001,093,93301,096,3631,096,3631,096,3631,100,0471,100,0471,100,3471,100,7871,100,7871,100,7871,100,9071,100,9071,091,8871,091,8871,091,8871,091,8871,091,8871,091,8871,091,8871,091,8871,091,8871,091,8871,091,8871,091,887960,855960,855960,855960,855960,855960,855960,855960,855960,855960,855960,855960,855960,855960,855960,855960,855960,855542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890542,890453,285453,285453,285453,285251,825251,825251,825251,825251,825251,825251,825251,825251,825251,825251,825251,825193,712193,712193,712193,712149,009149,009149,009104,009
   Retained Earnings 
57,100
29,059
34,256
53,502
62,233
79,997
48,552
103,814
119,891
139,479
163,625
185,851
162,708
179,807
197,548
189,580
211,462
228,934
240,803
253,435
256,550
265,365
267,668
272,241
272,346
278,560
284,576
281,384
296,054
310,449
320,215
331,128
329,711
346,529
363,694
374,835
376,029
398,597
429,374
443,893
444,155
467,376
496,118
511,899
513,457
539,893
567,656
579,237
585,974
604,965
603,948
755,454
757,936
781,588
809,387
823,749
829,628
853,897
861,207
877,068
876,855
887,516
900,991
908,922
1,052,382
1,078,049
1,114,434
1,143,071
1,151,480
1,188,293
1,228,576
1,068,167
1,039,588
1,060,618
1,304,269
1,343,025
1,378,969
1,394,360
1,331,272
1,356,691
1,366,794
1,373,589
1,368,940
1,391,486
1,414,455
1,405,160
1,389,034
1,223,112
1,501,557
1,289,337
1,257,721
1,257,7211,289,3371,501,5571,223,1121,389,0341,405,1601,414,4551,391,4861,368,9401,373,5891,366,7941,356,6911,331,2721,394,3601,378,9691,343,0251,304,2691,060,6181,039,5881,068,1671,228,5761,188,2931,151,4801,143,0711,114,4341,078,0491,052,382908,922900,991887,516876,855877,068861,207853,897829,628823,749809,387781,588757,936755,454603,948604,965585,974579,237567,656539,893513,457511,899496,118467,376444,155443,893429,374398,597376,029374,835363,694346,529329,711331,128320,215310,449296,054281,384284,576278,560272,346272,241267,668265,365256,550253,435240,803228,934211,462189,580197,548179,807162,708185,851163,625139,479119,891103,81448,55279,99762,23353,50234,25629,05957,100
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,814
6,936
2,394
3,565
4,029
6,229
109,591
105,864
155,614
160,379
244,532
248,884
245,972
200,657
207,877
209,535
193,034
222,265
170,351
172,873
178,419
0
0
00178,419172,873170,351222,265193,034209,535207,877200,657245,972248,884244,532160,379155,614105,864109,5916,2294,0293,5652,3946,9365,81400000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,782,827
Cost of Revenue-2,026,643
Gross Profit1,756,1841,756,184
 
Operating Income (+$)
Gross Profit1,756,184
Operating Expense-3,538,536
Operating Income244,291-1,782,352
 
Operating Expense (+$)
Research Development161,126
Selling General Administrative1,133,118
Selling And Marketing Expenses0
Operating Expense3,538,5361,294,244
 
Net Interest Income (+$)
Interest Income8,572
Interest Expense-36,682
Other Finance Cost-10,899
Net Interest Income-17,211
 
Pretax Income (+$)
Operating Income244,291
Net Interest Income-17,211
Other Non-Operating Income Expenses0
Income Before Tax (EBT)168,240244,291
EBIT - interestExpense = -36,682
117,053
153,735
Interest Expense36,682
Earnings Before Interest and Taxes (EBIT)0204,922
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax168,240
Tax Provision-5,567
Net Income From Continuing Ops162,673162,673
Net Income117,053
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net017,211
 

Technical Analysis of Tianjin Tianyao Pharmaceuticals Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tianjin Tianyao Pharmaceuticals Co Ltd. The general trend of Tianjin Tianyao Pharmaceuticals Co Ltd is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tianjin Tianyao Pharmaceuticals Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tianjin Tianyao Pharmaceuticals Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 3.79 < 3.82 < 4.05.

The bearish price targets are: 3.1.

Tweet this
Tianjin Tianyao Pharmaceuticals Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tianjin Tianyao Pharmaceuticals Co Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTianjin Tianyao Pharmaceuticals Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tianjin Tianyao Pharmaceuticals Co Ltd. The current adx is .

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Relative Strength Index (RSI) ChartTianjin Tianyao Pharmaceuticals Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Stochastic Oscillator ChartTianjin Tianyao Pharmaceuticals Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Commodity Channel Index (CCI) ChartTianjin Tianyao Pharmaceuticals Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Chande Momentum Oscillator (CMO) ChartTianjin Tianyao Pharmaceuticals Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Williams %R ChartTianjin Tianyao Pharmaceuticals Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Average True Range (ATR) ChartTianjin Tianyao Pharmaceuticals Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily On-Balance Volume (OBV) ChartTianjin Tianyao Pharmaceuticals Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tianjin Tianyao Pharmaceuticals Co Ltd.

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Money Flow Index (MFI) ChartTianjin Tianyao Pharmaceuticals Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tianjin Tianyao Pharmaceuticals Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-03CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Tianjin Tianyao Pharmaceuticals Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tianjin Tianyao Pharmaceuticals Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose3.760
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tianjin Tianyao Pharmaceuticals Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Tianjin Tianyao Pharmaceuticals Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tianjin Tianyao Pharmaceuticals Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tianjin Tianyao Pharmaceuticals Co Ltd

I send you an email if I find something interesting about Tianjin Tianyao Pharmaceuticals Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Tianjin Tianyao Pharmaceuticals Co Ltd.

Receive notifications about Tianjin Tianyao Pharmaceuticals Co Ltd in your mailbox!